OA01.06 First-Line Chemotherapy With or Without Tislelizumab for Extensive-Stage Small Cell Lung Cancer: RATIONALE-312 Phase 3 Study

Yi-Kan Cheng, Yong Song, Yao Zhao et al.|Journal of Thoracic Oncology|2023

Cited by 23